(RYTM) – Analyst Ratings
-
Morgan Stanley Upgrades Rhythm Pharmaceuticals (RYTM) to Overweight
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $42 at Goldman Sachs
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to RYTM Stock Lookup